SANGINITA2026-01-012026-03-31SANGINITA2026-03-31SANGINITA2025-03-31SANGINITA2025-04-012026-03-31SANGINITA2026-01-012026-03-31in-capmkt:OtherExpenses1MemberSANGINITA2025-04-012026-03-31in-capmkt:OtherExpenses1MemberSANGINITA2026-03-31OtherNoncurrentAssetsDomain1SANGINITA2026-03-31OtherCurrentAssetsDomain1SANGINITA2026-03-31OtherCurrentLiabilitiesDomain1SANGINITA2026-01-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1SANGINITA2025-04-012026-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1SANGINITA2026-01-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss1SANGINITA2025-04-012026-03-31ItemsThatWillBeReclassifiedToProfitAndLoss1SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain1SANGINITA2025-12-31RelatedPartyTransactionDomain1SANGINITA2026-03-31RelatedPartyTransactionDomain1SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain2SANGINITA2025-12-31RelatedPartyTransactionDomain2SANGINITA2026-03-31RelatedPartyTransactionDomain2SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain3SANGINITA2025-12-31RelatedPartyTransactionDomain3SANGINITA2026-03-31RelatedPartyTransactionDomain3SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain4SANGINITA2025-12-31RelatedPartyTransactionDomain4SANGINITA2026-03-31RelatedPartyTransactionDomain4SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain5SANGINITA2025-12-31RelatedPartyTransactionDomain5SANGINITA2026-03-31RelatedPartyTransactionDomain5SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain6SANGINITA2025-12-31RelatedPartyTransactionDomain6SANGINITA2026-03-31RelatedPartyTransactionDomain6SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain7SANGINITA2025-12-31RelatedPartyTransactionDomain7SANGINITA2026-03-31RelatedPartyTransactionDomain7SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain8SANGINITA2025-12-31RelatedPartyTransactionDomain8SANGINITA2026-03-31RelatedPartyTransactionDomain8SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain9SANGINITA2025-12-31RelatedPartyTransactionDomain9SANGINITA2026-03-31RelatedPartyTransactionDomain9SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain10SANGINITA2025-12-31RelatedPartyTransactionDomain10SANGINITA2026-03-31RelatedPartyTransactionDomain10SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain11SANGINITA2025-12-31RelatedPartyTransactionDomain11SANGINITA2026-03-31RelatedPartyTransactionDomain11SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain12SANGINITA2025-12-31RelatedPartyTransactionDomain12SANGINITA2026-03-31RelatedPartyTransactionDomain12SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain13SANGINITA2025-12-31RelatedPartyTransactionDomain13SANGINITA2026-03-31RelatedPartyTransactionDomain13SANGINITA2026-01-012026-03-31RelatedPartyTransactionDomain14SANGINITA2025-12-31RelatedPartyTransactionDomain14SANGINITA2026-03-31RelatedPartyTransactionDomain14SANGINITA2026-01-012026-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares000000SANGINITANOTLISTEDINE753W01010Sanginita Chemicals LimitedMain BoardEquity2025-04-012026-03-312026-04-252026-04-13INRLakhsQuarterlyFourth quarterSingle segmentChemicals2026-04-2515:00:002026-04-2516:00:00trueCash Flow IndirectDeclaration of unmodified opiniontruetrueNANAfalsetrue2022-04-01https://www.sanginitachemicals.co.in/Investor-Relation/g-01.pdffalsefalseNot Applicable2026-01-012026-03-31AuditedStandalone4297170003000429720000224656000255552000-29690001912000434500054090004220000493125000-634050000-634050000-118000-1180000-632870000000-632870000-6328700025901600010-2.44-2.4400-2.44-2.441. The above Audited Results have been reviewed by the Audit Committee and taken on record by Board of Directors at their respective meetings held on 25th April, 2026 and the same have been audited by the Statutory Auditors of the Company. <BR> 2. Figures for the quarter ended 31st March, 2026 and the corresponding quarter ended in the previous year as reported in these financial results are the balancing figures between audited figures in respect of the full financial year and the published year to the date figures up to the end of the third quarter of the relevant financial year. <BR> 3. The figures for the corresponding previous period have been restated/regrouped wherever necessary, to make them comparable. <BR> 4. The company operates in single operating segment i.e. Chemicals. <BR> 5. The Company does not have any Subsidiary, Associate or Joint Venture Company. Hence, Consolidated Financial Results are not applicable to the Company. <BR> 6. Share Swap and Share Purchase Agreement (“SSSPA”) dated 20th March, 2026 has been entered into amongst the Company, its existing Promoter and Promoter Group, B N G Investment LLC, Mr. Anubhav Agarwal and Agastya Green Energy Limited (AGEL) by which the existing Promoters and promoters group have agreed to transfer their entire shareholding in the Company to the B N G Investment LLC and Mr. Anubhav Agrawal. Moreover, subject to all applicable approvals, and in terms of approval of the members of the Company at the EGM held on 11th April 2026, the members have approved issuance of up to 1,52,87,356 (One Crore Fifty Two Lakh Eighty Seven Thousand Three Hundred Fifty Six only) equity shares of face value of Rs.10/- each (Rupees Ten Only) fully paid-up by way of share swap to B N G Investment LLC in lieu of consideration other than cash wherein the Company is purchasing 95,00,000 shares of Rs. 10 each at a price of Rs. 21/- each of Agastya Green Energy Limited (“AGEL”) and also for the issuance of up to 1,91,57,080 (One Crore Ninety One Lakh Fifty Seven Thousand Eighty only) equity shares of face value of Rs.10/- each (Rupees Ten Only) fully paid-up to B N G Investment LLC at an issue price of Rs.13.05/- (Rupees Thirteen and Paise Five Only) per equity share total aggregating to Rs. 24,99,99,894 /- (Rupees Twenty Four Crore Ninety Nine Lakh Ninety Nine Thousand Eight Hundred Ninety Four only) on a preferential basis for the consideration in cash under the promoter category (“Proposed Allottee”), in accordance with the SEBI (ICDR) Regulations and other applicable laws. The Company has already made application to NSE for seeking in principle approval for the same. This transaction is subject to all applicable approvals and process. <BR> 7.The New Labour Codes (the 'Codes') have been notified by the Government of lndia on November 21, 2025. While the Central Government has issued draft rules, the relevant State Government rules, which are necessary for determining the final financial impact on various employee benefits, are currently under public consultation and yet to be finalized. Consequently, the Company has not yet revised its employee benefit valuations. The Company will assess the impact and make necessary provisions once the rules are finalized and the effective date for specific implementation is clearer.2025-04-012026-03-31AuditedStandalone176458100038470001768428000892633000919652000-1178000097670001920900021915000142840001865680000-972520000-972520000-379000-3790000-968730000000-968730000-9687300025901600010205558000-3.74-3.7400-3.74-3.74Other Expenses4220000Other Expenses1428400012804900000000000000024060001304550001913060000264062000436000002644980000180053000635857000007663120002590160002055580004645740004645740003132700000031327000017990000331260009138300024866000117881000142747000234130000344820000268612000301738000766312000Other Non Current Assets2406000Other Current Assets180053000Other Current Liabilities3448200019209000106054000102267000024775000000068130000-242860000219150000000000000000-37780000252969000155717000000001557170000000000076000002942000000000000000000000720000105000483500000000000212620001623130000019209000015000-1602450003070000307000129000436000Amount of items that will not be reclassified to Profit and Loss00Amount of items that will not be reclassified to Profit and Loss0000Amount of items that will not be reclassified to Profit and Loss00Amount of items that will not be reclassified to Profit and Loss000000Sanginita Chemicals Limited******Dineshsinh B. Chavada******Chairperson and DirectorRemuneration600000NA02025-04-22000Sanginita Chemicals Limited******Dineshsinh B. Chavada******Chairperson and DirectorLoan20000000Overall limit02025-04-22110640001076000021460000Sanginita Chemicals Limited******Dineshsinh B. Chavada******Chairperson and DirectorAny other transactionReimbursement of Expenses0NA02025-04-2214600000Sanginita Chemicals Limited******Dineshsinh B. Chavada******Chairperson and DirectorSale of fixed assets200000Overall limit02026-01-1017700000Sanginita Chemicals Limited******Hansaben D. Chavada******DirectorAny other transactionLease Rent480000NA02025-04-2224000000Sanginita Chemicals Limited******Hansaben D. Chavada******DirectorLoan15000000Overall limit02025-04-22207400040950005176000Sanginita Chemicals Limited******Hansaben D. Chavada******DirectorSale of fixed assets120000Overall limit02026-01-1010900000Sanginita Chemicals Limited******Vijaysinh D. Chavda******Whole Time DirectorRemuneration780000Overall limit02025-10-1048000000Sanginita Chemicals Limited******Vijaysinh D. Chavda******Whole Time DirectorLoan20000000Overall limit02025-04-22352000011750004691000Sanginita Chemicals Limited******Vijaysinh D. Chavda******Whole Time DirectorAny other transactionReimbursement of Expenses0NA02025-04-2216300000Sanginita Chemicals Limited******Vijaysinh D. Chavda******Whole Time DirectorSale of fixed assets100000Overall limit02026-01-10200000Sanginita Chemicals Limited******Anita R Aswar******Relative of DirectorsLoan10000000Overall limit02025-04-22373000000Sanginita Chemicals Limited******Anita R Aswar******Relative of DirectorsSale of fixed assets8000000Overall limit02025-04-22781500000Sanginita Chemicals Limited******Sanginita Industries LLP******Related PartyLoan20000000Overall limit02025-04-22110350002535000040555000AuditedtrueB K Chavda & Co.true2027-05-31